Previous 10 | Next 10 |
home / stock / medif / medif news
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) announced its revenues fell to $4.9 million for the third quarter ending September 30, 2020, versus $13.9 million for the second quarter of 2020. This was a massive decline from last year’s revenue of $43 million for the...
BARRIE, Ontario, Nov. 16, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and derivative products today annou...
MediPharm Labs' ([[MEDIF]] +0.3%) has announced that its CFO, Bobby Kwon, will leave the company, but will serve in his current position to the end of November, when an interim CFO will be appointed.The Company will also commence a search for new CFO by end of this month. For further d...
BARRIE, Ontario, Nov. 12, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, today anno...
BARRIE, Ontario, Oct. 29, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivati...
TORONTO, Oct. 28, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivativ...
MediPharm Labs' (MEDIF) wholly owned subsidiary, MediPharm Labs Australia entered into a new white-label supply agreement with Sunco Green Pharmaceutical for bringing GMP certified cannabis products to a growing Australian cannabis and emerging New Zealand market.Under the two-year agreement,...
MediPharm and Sunco Green to bring GMP certified cannabis products to a burgeoning Australian cannabis market beginning in Q4 2020 In September 2020, over 6,000 patients were approved for medical cannabis treatment in Australia an 72% increase from approvals granted nearly 1 year ...
BARRIE, Ontario, Oct. 20, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivati...
MediPharm Labs ([[MEDIF]] +0.6%) subsidiary, MediPharm Labs Inc., has initiated a clinical trial to research and evaluate the effectiveness of MediPharm Labs’ proprietary cannabis-derived medical products and formulations on the treatment of end-stage renal disease or Chronic Kidney Di...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders Canada NewsWire TORONTO , June 26, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical comp...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols Canada NewsWire MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Product...